Page last updated: 2024-10-25

cilostamide and Myocardial Infarction

cilostamide has been researched along with Myocardial Infarction in 2 studies

cilostamide: selective inhibitor of cyclic AMP phosphodiesterase & platelet aggregation; structure

Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, YW1
Lagranha, C1
Chen, Y1
Sun, J1
Tong, G1
Hockman, SC1
Ahmad, F1
Esfahani, SG1
Bae, DH1
Polidovitch, N1
Wu, J1
Rhee, DK1
Lee, BS1
Gucek, M1
Daniels, MP1
Brantner, CA1
Backx, PH1
Murphy, E1
Manganiello, VC1
Hussain, RI1
Aronsen, JM1
Afzal, F1
Sjaastad, I1
Osnes, JB1
Skomedal, T1
Levy, FO1
Krobert, KA1

Other Studies

2 other studies available for cilostamide and Myocardial Infarction

ArticleYear
Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury.
    Proceedings of the National Academy of Sciences of the United States of America, 2015, Apr-28, Volume: 112, Issue:17

    Topics: Animals; Caveolin 3; Connexin 43; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotid

2015
The functional activity of inhibitory G protein (G(i)) is not increased in failing heart ventricle.
    Journal of molecular and cellular cardiology, 2013, Volume: 56

    Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Carbachol; Cardiotonic Agents; GTP-Binding Pro

2013